Main Logo
+17162654855
[email protected]

Deep Dive into North America Companion Diagnostics Devices Market: Comprehensive Growth Analysis 2026-2034

North America Companion Diagnostics Devices Market by Technology (Immunohistochemistry (IHC), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Real-time PCR (RT-PCR), Gene Sequencing, Other Technologies), by Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Melanoma, Other Indications), by Geography (North America), by North America (United States, Canada, Mexico) Forecast 2026-2034

Base Year: 2025
120 Pages
Main Logo

Deep Dive into North America Companion Diagnostics Devices Market: Comprehensive Growth Analysis 2026-2034

About Precision Market View

Precision Market View offers precise market research, industry intelligence, and data analysis for healthcare, manufacturing, technology, and energy. Our reports provide the clarity you need to make informed decisions and drive growth.

Our team combines primary research, advanced analytics, and industry expertise to deliver actionable intelligence. We offer syndicated reports, custom research, and consulting services tailored to your business needs.

At Precision Market View, we are committed to quality, transparency, and client satisfaction. Every report is rigorously validated to ensure accuracy and relevance. Our global perspective and local expertise help you understand both the big picture and the finer details of your market.

Stay informed with Precision Market View. Subscribe to our newsletter for the latest updates and research highlights, and follow us on social media for real-time insights.

Precision Market View – Clarity for Your Strategic Decisions.

Geographic Coverage of North America Companion Diagnostics Devices Market

Higher Coverage
Lower Coverage
No Coverage

North America Companion Diagnostics Devices Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2020-2034
Base Year 2025
Estimated Year 2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 18.50% from 2020-2034
Segmentation
    • By Technology
      • Immunohistochemistry (IHC)
      • Polymerase Chain Reaction (PCR)
      • In-situ Hybridization (ISH)
      • Real-time PCR (RT-PCR)
      • Gene Sequencing
      • Other Technologies
    • By Indication
      • Lung Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Leukemia
      • Melanoma
      • Other Indications
    • By Geography
      • North America
        • United States
        • Canada
        • Mexico
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico

Table of Contents

  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Objective
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Market Snapshot
  3. 3. Market Dynamics
    • 3.1. Market Drivers
    • 3.2. Market Restrains
    • 3.3. Market Trends
    • 3.4. Market Opportunities
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
      • 4.1.1. Bargaining Power of Suppliers
      • 4.1.2. Bargaining Power of Buyers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
    • 4.2. PESTEL analysis
    • 4.3. BCG Analysis
      • 4.3.1. Stars (High Growth, High Market Share)
      • 4.3.2. Cash Cows (Low Growth, High Market Share)
      • 4.3.3. Question Mark (High Growth, Low Market Share)
      • 4.3.4. Dogs (Low Growth, Low Market Share)
    • 4.4. Ansoff Matrix Analysis
    • 4.5. Supply Chain Analysis
    • 4.6. Regulatory Landscape
    • 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
    • 4.8. PMV Analyst Note
  5. 5. Market Analysis, Insights and Forecast 2021-2033
    • 5.1. Market Analysis, Insights and Forecast - by Technology
      • 5.1.1. Immunohistochemistry (IHC)
      • 5.1.2. Polymerase Chain Reaction (PCR)
      • 5.1.3. In-situ Hybridization (ISH)
      • 5.1.4. Real-time PCR (RT-PCR)
      • 5.1.5. Gene Sequencing
      • 5.1.6. Other Technologies
    • 5.2. Market Analysis, Insights and Forecast - by Indication
      • 5.2.1. Lung Cancer
      • 5.2.2. Breast Cancer
      • 5.2.3. Colorectal Cancer
      • 5.2.4. Leukemia
      • 5.2.5. Melanoma
      • 5.2.6. Other Indications
    • 5.3. Market Analysis, Insights and Forecast - by Geography
      • 5.3.1. North America
        • 5.3.1.1. United States
        • 5.3.1.2. Canada
        • 5.3.1.3. Mexico
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. North America
  6. 6. North America Companion Diagnostics Devices Market Analysis, Insights and Forecast, 2021-2033
    • 6.1. Market Analysis, Insights and Forecast - by Technology
      • 6.1.1. Immunohistochemistry (IHC)
      • 6.1.2. Polymerase Chain Reaction (PCR)
      • 6.1.3. In-situ Hybridization (ISH)
      • 6.1.4. Real-time PCR (RT-PCR)
      • 6.1.5. Gene Sequencing
      • 6.1.6. Other Technologies
    • 6.2. Market Analysis, Insights and Forecast - by Indication
      • 6.2.1. Lung Cancer
      • 6.2.2. Breast Cancer
      • 6.2.3. Colorectal Cancer
      • 6.2.4. Leukemia
      • 6.2.5. Melanoma
      • 6.2.6. Other Indications
    • 6.3. Market Analysis, Insights and Forecast - by Geography
      • 6.3.1. North America
        • 6.3.1.1. United States
        • 6.3.1.2. Canada
        • 6.3.1.3. Mexico
  7. 7. Competitive Analysis
      • 7.1. Company Profiles
        • 7.1.1 Laboratory Corporation of America Holdings (Labcorp)
          • 7.1.1.1. Company Overview
          • 7.1.1.2. Products
          • 7.1.1.3. Company Financials
          • 7.1.1.4. SWOT Analysis
        • 7.1.2 Novartis AG
          • 7.1.2.1. Company Overview
          • 7.1.2.2. Products
          • 7.1.2.3. Company Financials
          • 7.1.2.4. SWOT Analysis
        • 7.1.3 Biomerieux SA
          • 7.1.3.1. Company Overview
          • 7.1.3.2. Products
          • 7.1.3.3. Company Financials
          • 7.1.3.4. SWOT Analysis
        • 7.1.4 Siemens Healthineers
          • 7.1.4.1. Company Overview
          • 7.1.4.2. Products
          • 7.1.4.3. Company Financials
          • 7.1.4.4. SWOT Analysis
        • 7.1.5 F Hoffmann-La Roche Ltd
          • 7.1.5.1. Company Overview
          • 7.1.5.2. Products
          • 7.1.5.3. Company Financials
          • 7.1.5.4. SWOT Analysis
        • 7.1.6 Thermo Fisher Scientific Inc
          • 7.1.6.1. Company Overview
          • 7.1.6.2. Products
          • 7.1.6.3. Company Financials
          • 7.1.6.4. SWOT Analysis
        • 7.1.7 Abbott Laboratories
          • 7.1.7.1. Company Overview
          • 7.1.7.2. Products
          • 7.1.7.3. Company Financials
          • 7.1.7.4. SWOT Analysis
        • 7.1.8 ARUP Laboratories
          • 7.1.8.1. Company Overview
          • 7.1.8.2. Products
          • 7.1.8.3. Company Financials
          • 7.1.8.4. SWOT Analysis
        • 7.1.9 Agilent Technologies Inc
          • 7.1.9.1. Company Overview
          • 7.1.9.2. Products
          • 7.1.9.3. Company Financials
          • 7.1.9.4. SWOT Analysis
        • 7.1.10 Qiagen NV
          • 7.1.10.1. Company Overview
          • 7.1.10.2. Products
          • 7.1.10.3. Company Financials
          • 7.1.10.4. SWOT Analysis
        • 7.1.11 Amgen Inc *List Not Exhaustive
          • 7.1.11.1. Company Overview
          • 7.1.11.2. Products
          • 7.1.11.3. Company Financials
          • 7.1.11.4. SWOT Analysis
        • 7.1.12 Danaher Corporation (Beckman Coulter Inc )
          • 7.1.12.1. Company Overview
          • 7.1.12.2. Products
          • 7.1.12.3. Company Financials
          • 7.1.12.4. SWOT Analysis
      • 7.2. Market Entropy
        • 7.2.1 Company's Key Areas Served
        • 7.2.2 Recent Developments
      • 7.3. Company Market Share Analysis 2025
        • 7.3.1 Top 5 Companies Market Share Analysis
        • 7.3.2 Top 3 Companies Market Share Analysis
    • 7.4. List of Potential Customers
  8. 8. Research Methodology

    List of Figures

    1. Figure 1: North America Companion Diagnostics Devices Market Revenue Breakdown (Million, %) by Product 2025 & 2033
    2. Figure 2: North America Companion Diagnostics Devices Market Share (%) by Company 2025

    List of Tables

    1. Table 1: North America Companion Diagnostics Devices Market Revenue Million Forecast, by Technology 2020 & 2033
    2. Table 2: North America Companion Diagnostics Devices Market Volume K Units Forecast, by Technology 2020 & 2033
    3. Table 3: North America Companion Diagnostics Devices Market Revenue Million Forecast, by Indication 2020 & 2033
    4. Table 4: North America Companion Diagnostics Devices Market Volume K Units Forecast, by Indication 2020 & 2033
    5. Table 5: North America Companion Diagnostics Devices Market Revenue Million Forecast, by Geography 2020 & 2033
    6. Table 6: North America Companion Diagnostics Devices Market Volume K Units Forecast, by Geography 2020 & 2033
    7. Table 7: North America Companion Diagnostics Devices Market Revenue Million Forecast, by Region 2020 & 2033
    8. Table 8: North America Companion Diagnostics Devices Market Volume K Units Forecast, by Region 2020 & 2033
    9. Table 9: North America Companion Diagnostics Devices Market Revenue Million Forecast, by Technology 2020 & 2033
    10. Table 10: North America Companion Diagnostics Devices Market Volume K Units Forecast, by Technology 2020 & 2033
    11. Table 11: North America Companion Diagnostics Devices Market Revenue Million Forecast, by Indication 2020 & 2033
    12. Table 12: North America Companion Diagnostics Devices Market Volume K Units Forecast, by Indication 2020 & 2033
    13. Table 13: North America Companion Diagnostics Devices Market Revenue Million Forecast, by Geography 2020 & 2033
    14. Table 14: North America Companion Diagnostics Devices Market Volume K Units Forecast, by Geography 2020 & 2033
    15. Table 15: North America Companion Diagnostics Devices Market Revenue Million Forecast, by Country 2020 & 2033
    16. Table 16: North America Companion Diagnostics Devices Market Volume K Units Forecast, by Country 2020 & 2033
    17. Table 17: United States North America Companion Diagnostics Devices Market Revenue (Million) Forecast, by Application 2020 & 2033
    18. Table 18: United States North America Companion Diagnostics Devices Market Volume (K Units) Forecast, by Application 2020 & 2033
    19. Table 19: Canada North America Companion Diagnostics Devices Market Revenue (Million) Forecast, by Application 2020 & 2033
    20. Table 20: Canada North America Companion Diagnostics Devices Market Volume (K Units) Forecast, by Application 2020 & 2033
    21. Table 21: Mexico North America Companion Diagnostics Devices Market Revenue (Million) Forecast, by Application 2020 & 2033
    22. Table 22: Mexico North America Companion Diagnostics Devices Market Volume (K Units) Forecast, by Application 2020 & 2033

    Frequently Asked Questions

    1. What is the projected Compound Annual Growth Rate (CAGR) of the North America Companion Diagnostics Devices Market?

    The projected CAGR is approximately 18.50%.

    2. Which companies are prominent players in the North America Companion Diagnostics Devices Market?

    Key companies in the market include Laboratory Corporation of America Holdings (Labcorp), Novartis AG, Biomerieux SA, Siemens Healthineers, F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, ARUP Laboratories, Agilent Technologies Inc, Qiagen NV, Amgen Inc *List Not Exhaustive, Danaher Corporation (Beckman Coulter Inc ).

    3. What are the main segments of the North America Companion Diagnostics Devices Market?

    The market segments include Technology, Indication, Geography.

    4. Can you provide details about the market size?

    The market size is estimated to be USD 2.5 Million as of 2022.

    5. What are some drivers contributing to market growth?

    Increasing Demand and Awareness for Personalized Medicine and Targeted Therapy; Increasing Cases of Adverse Drug Reactions; Technological Advancements in the Devices.

    6. What are the notable trends driving market growth?

    The In-situ Hybridization (ISH) Segment is Expected to Exhibit the Fastest Growth Rate over the Forecast Period.

    7. Are there any restraints impacting market growth?

    High Cost of Drug Development and Associated Clinical Trials.

    8. Can you provide examples of recent developments in the market?

    In January 2023, QIAGEN entered into an exclusive strategic partnership with Helix o advance companion diagnostics for hereditary diseases such as cardiovascular, metabolic, neurodegenerative, auto-immune diseases, and others. Under the terms of the agreement, QIAGEN will be the exclusive marketing and contracting partner in the United States for Helix's companion diagnostic services.

    9. What pricing options are available for accessing the report?

    Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.

    10. Is the market size provided in terms of value or volume?

    The market size is provided in terms of value, measured in Million and volume, measured in K Units.

    11. Are there any specific market keywords associated with the report?

    Yes, the market keyword associated with the report is "North America Companion Diagnostics Devices Market," which aids in identifying and referencing the specific market segment covered.

    12. How do I determine which pricing option suits my needs best?

    The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

    13. Are there any additional resources or data provided in the North America Companion Diagnostics Devices Market report?

    While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

    14. How can I stay updated on further developments or reports in the North America Companion Diagnostics Devices Market?

    To stay informed about further developments, trends, and reports in the North America Companion Diagnostics Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

    Methodology

    Step 1 - Identification of Relevant Samples Size from Population Database

    Step Chart
    Bar Chart
    Method Chart

    Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

    Approach Chart
    Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

    Note*: In applicable scenarios

    Step 3 - Data Sources

    Primary Research

    • Web Analytics
    • Survey Reports
    • Research Institute
    • Latest Research Reports
    • Opinion Leaders

    Secondary Research

    • Annual Reports
    • White Paper
    • Latest Press Release
    • Industry Association
    • Paid Database
    • Investor Presentations
    Analyst Chart

    Step 4 - Data Triangulation

    Involves using different sources of information in order to increase the validity of a study

    These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

    Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

    During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

    Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.